Objective Patients with probable dementia with Lewy bodies (DLB) often have Alzheimer's
disease (AD)‐related pathology. Our objective was to determine the pattern of positron …

Objective β-Amyloid (Aβ) pathology is common in patients with probable dementia with
Lewy bodies (DLB). However, the pathologic basis and the differential diagnostic …

Objective In a multicenter cohort of probable dementia with Lewy bodies (DLB), we tested
the hypothesis that β-amyloid and tau biomarker positivity increases with age, which is …

Alzheimer's disease pathology frequently coexists with Lewy body disease at autopsy in
patients with probable dementia with Lewy bodies. More than half of patients with probable …

Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative
dementia after Alzheimer's disease (AD). Our objective was to determine whether the 11C …

A significant proportion of patients with dementia with Lewy bodies (DLB) show Alzheimer's
disease (AD) pathology like senile plaques and neurofibrillary tangles. Biomarkers in …

Importance Plasma phosphorylated tau (p-tau) has proven to be an accurate biomarker for
Alzheimer disease (AD) pathologic characteristics, offering a less expensive and less …

Background: Extrapyramidal motor symptoms precede dementia in Parkinson disease
(PDD) by many years, whereas dementia occurs early in dementia with Lewy bodies (DLB) …

Background Most patients with dementia with Lewy bodies (DLB) exhibit diffuse plaque–
only pathology with rare neocortical neurofibrillary tangles (NFTs), as opposed to the …

Objective: To address the relationship between dementia and neuropathologic findings in
dementia with Lewy bodies (DLB) in comparison with AD. Methods: We evaluated the …